We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Community Health Sells 2 Texas Units, Streamlines Business
Read MoreHide Full Article
Community Health Systems, Inc.’s (CYH - Free Report) subsidiaries have sold their ownership interest in two Texas hospitals and their associated assets to subsidiaries of HCA Healthcare Inc. (HCA - Free Report) . The units divested include a 350-bed Tomball Regional Medical Center in Tomball and a 67-bed South Texas Regional Medical Center in Jourdanton.
The company is burdened with long-term debt and has therefore implemented portfolio rationalization and a deleveraging strategy by divesting hospitals and non-hospital businesses. Generally, these business lines are not in one of the company’s strategically beneficial service areas, are less complementary to its business strategy and have lower operating margin.
Significant divestitures and a consequent decrease in debt level have helped the company to gain investors’ faith as evident by its stock price increase of 78% year to date compared with the gain of 18% for the Zacks categorized Medical-Hospital industry.
The two hospitals sold recently are part of the 30 planned hospital divestitures discussed on the company’s first-quarter 2017 earnings call. This divestiture plan accounts for approximately $3.4 billion of annual revenue and mid-single digit EBITDA margins. Estimated gross proceeds from these divestitures including working capital are projected at $2 billion.
Community Health expects the transaction for these hospitals to close during the first nine months of 2017. This business restructuring will reduce the number of divisions to four and improve the company’s overall efficiency.
Along with improving its debt-EBITDA ratio, Community Health is working to reduce its overall debt. Its current divestiture plan will allow the company to move to a portfolio of hospitals that are better positioned to drive volume growth, EBITDA margin and cash flow. It will also allow the company to direct future investments to the most attractive markets and regional networks that provide a higher return on capital.
Another player in the same industry, Tenet Healthcare Corporation (THC - Free Report) , recently inked a deal with Amedisys, Inc. (AMED - Free Report) to divest its Home Health and Hospice operations in Arizona, Illinois, Massachusetts and Texas.
5 Trades Could Profit ""Big-League"" from Trump Policies
If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.
Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure.See these buy recommendations now >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Community Health Sells 2 Texas Units, Streamlines Business
Community Health Systems, Inc.’s (CYH - Free Report) subsidiaries have sold their ownership interest in two Texas hospitals and their associated assets to subsidiaries of HCA Healthcare Inc. (HCA - Free Report) . The units divested include a 350-bed Tomball Regional Medical Center in Tomball and a 67-bed South Texas Regional Medical Center in Jourdanton.
The company is burdened with long-term debt and has therefore implemented portfolio rationalization and a deleveraging strategy by divesting hospitals and non-hospital businesses. Generally, these business lines are not in one of the company’s strategically beneficial service areas, are less complementary to its business strategy and have lower operating margin.
Significant divestitures and a consequent decrease in debt level have helped the company to gain investors’ faith as evident by its stock price increase of 78% year to date compared with the gain of 18% for the Zacks categorized Medical-Hospital industry.
The two hospitals sold recently are part of the 30 planned hospital divestitures discussed on the company’s first-quarter 2017 earnings call. This divestiture plan accounts for approximately $3.4 billion of annual revenue and mid-single digit EBITDA margins. Estimated gross proceeds from these divestitures including working capital are projected at $2 billion.
Community Health expects the transaction for these hospitals to close during the first nine months of 2017. This business restructuring will reduce the number of divisions to four and improve the company’s overall efficiency.
Along with improving its debt-EBITDA ratio, Community Health is working to reduce its overall debt. Its current divestiture plan will allow the company to move to a portfolio of hospitals that are better positioned to drive volume growth, EBITDA margin and cash flow. It will also allow the company to direct future investments to the most attractive markets and regional networks that provide a higher return on capital.
Another player in the same industry, Tenet Healthcare Corporation (THC - Free Report) , recently inked a deal with Amedisys, Inc. (AMED - Free Report) to divest its Home Health and Hospice operations in Arizona, Illinois, Massachusetts and Texas.
Community Health carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
5 Trades Could Profit ""Big-League"" from Trump Policies
If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.
Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>